| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
2e-10 |
| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
1e-07 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
3e-07 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
4e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |